Business Description
Humana Inc
NAICS : 621610
SIC : 6324
ISIN : US4448591028
Share Class Description:
FRA:HUM: Ordinary SharesCompare
Compare
Traded in other countries / regions
HUM.USA0J6Z.UKHUM.MexicoHUM.GermanyH1UM34.Brazil IPO Date
1971-05-18Description
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.39 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 0.74 | |||||
| Debt-to-EBITDA | 3.62 | |||||
| Interest Coverage | 4.1 | |||||
| Piotroski F-Score | 4/9 | |||||
| Beneish M-Score | -2.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.8 | |||||
| 3-Year EBITDA Growth Rate | -2.3 | |||||
| 3-Year EPS without NRI Growth Rate | 1 | |||||
| 3-Year FCF Growth Rate | -12 | |||||
| 3-Year Book Growth Rate | 7.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -16.21 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.93 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 79.48 | |||||
| 9-Day RSI | 64.32 | |||||
| 14-Day RSI | 56.59 | |||||
| 6-1 Month Momentum % | -21.41 | |||||
| 12-1 Month Momentum % | -35.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.28 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| 3-Year Dividend Growth Rate | 12.3 | |||||
| Forward Dividend Yield % | 1.32 | |||||
| 5-Year Yield-on-Cost % | 2.29 | |||||
| 3-Year Average Share Buyback Ratio | 1.7 | |||||
| Shareholder Yield % | 1.92 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Net Margin % | 1.18 | |||||
| FCF Margin % | -3.79 | |||||
| ROE % | 8.13 | |||||
| ROA % | 2.68 | |||||
| ROIC % | 7.08 | |||||
| 3-Year ROIIC % | -6.53 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.83 | |||||
| Forward PE Ratio | 16.18 | |||||
| PE Ratio without NRI | 17.05 | |||||
| Shiller PE Ratio | 13.7 | |||||
| PEG Ratio | 1.61 | |||||
| PS Ratio | 0.28 | |||||
| PB Ratio | 1.84 | |||||
| Price-to-Tangible-Book | 4.06 | |||||
| EV-to-EBIT | 15.32 | |||||
| EV-to-Forward-EBIT | 13.19 | |||||
| EV-to-EBITDA | 11.21 | |||||
| EV-to-Forward-EBITDA | 10.22 | |||||
| EV-to-Revenue | 0.35 | |||||
| EV-to-Forward-Revenue | 0.35 | |||||
| EV-to-FCF | -9.29 | |||||
| Price-to-Projected-FCF | 0.62 | |||||
| Price-to-DCF (Earnings Based) | 0.69 | |||||
| Price-to-Median-PS-Value | 0.43 | |||||
| Price-to-Graham-Number | 1.75 | |||||
| Earnings Yield (Greenblatt) % | 6.53 | |||||
| FCF Yield % | -13.41 | |||||
| Forward Rate of Return (Yacktman) % | 9.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Humana Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 105,437.131 | ||
| EPS (TTM) (€) | 10.375 | ||
| Beta | -0.59 | ||
| Volatility % | 37.79 | ||
| 14-Day RSI | 56.59 | ||
| 14-Day ATR (€) | 4.319224 | ||
| 20-Day SMA (€) | 244.81 | ||
| 12-1 Month Momentum % | -35.44 | ||
| 52-Week Range (€) | 191 - 412.3 | ||
| Shares Outstanding (Mil) | 120.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Humana Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Humana Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Humana Inc Frequently Asked Questions
What is Humana Inc(FRA:HUM)'s stock price today?
The current price of FRA:HUM is €259.40. The 52 week high of FRA:HUM is €412.30 and 52 week low is €191.00.
When is next earnings date of Humana Inc(FRA:HUM)?
The next earnings date of Humana Inc(FRA:HUM) is 2025-02-11.
Does Humana Inc(FRA:HUM) pay dividends? If so, how much?
The Dividend Yield %  of Humana Inc(FRA:HUM) is 1.28% (As of Today), Highest Dividend Payout Ratio of Humana Inc(FRA:HUM) was 0.22. The lowest was 0.1. And the median was 0.14. The  Forward Dividend Yield % of Humana Inc(FRA:HUM) is 1.32%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers